This site is intended for healthcare professionals
Drug news

Phase III trial of GSP 301 (mometasone furoate and olopatadine hydrochloride) shows significant improvement in seasonal allergic rhinitis- Glenmark Pharmaceuticals

Read time: 1 mins
Last updated:30th Mar 2017
Published:30th Mar 2017
Source: Pharmawand
Register free for full access to medthority.com